Drug Recall: Rosuvastatin 5mg Tablets for Manufacturing Deviations
RemedyRepack Inc. is recalling 399 bottles of Rosuvastatin 5mg tablets nationwide due to manufacturing deviations. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a FDA Class II voluntary recall with manufacturing deviations but no reported illnesses or injuries. Per the rubric, voluntary precautionary recalls with no reported incidents score as Moderate.
Plain-English summary
RemedyRepack Inc. is recalling 399 bottles of Rosuvastatin 5mg tablets due to manufacturing deviations. The recalled product was distributed nationwide to consignees. Affected lot numbers include J0668398-121422 (expiring 12/31/2023), J0661225-111522 and J0654053-101822 (expiring 11/30/2023), and J0646383-091422 (expiring 09/30/2023).
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations identified during the manufacturing process. This is a voluntary recall initiated by the firm.
No illnesses or injuries have been reported related to this product. The recall was initiated on March 20, 2023, and terminated on October 19, 2023. Healthcare providers and consumers who have this prescription medication should contact their pharmacist or healthcare provider for guidance.
The recalled product
- Product
- Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-3519-00.
- Manufacturer
- RemedyRepack Inc.
- Category
- Drug — Statin
- Hazard
- Affected units
- 399
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: J0668398-121422
- Exp. Date 12/31/2023
- J0661225-111522
- J0654053-101822 Exp. Date 11/30/2023
- J0646383-091422
- Exp. Date 09/30/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 14 recalled by RemedyRepack Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · RemedyRepack Inc.
See all →- ModerateClindamycin HCl Capsule 300 mg repackaged by RemedyRePack Inc.
FDA (Drugs) · 2025-05-14
- ModerateClindamycin HCl 300 mg Capsule Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-30
- HighCarvedilol 25 mg tablets recalled due to N-nitroso impurity above limit
FDA (Drugs) · 2025-02-12
- HighDuloxetine delayed-release capsules recalled due to manufacturing impurity
FDA (Drugs) · 2025-01-01
- HighPotassium Chloride Extended Release Capsules Recalled for Dissolution Defect
FDA (Drugs) · 2024-07-24
Same hazard · manufacturing deviation
See all →- ModerateSynjardy XR Tablets Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2026-07-08
- ModerateDuloxetine delayed-release capsules recalled for N-nitroso impurity contamination
FDA (Drugs) · 2026-05-13
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateiVIZIA Dry Eye Lubricant Drops Recalled for Sterility Assurance
FDA (Drugs) · 2026-05-06
- ModerateFurosemide tablets recalled for presence of N-nitroso impurity
FDA (Drugs) · 2026-04-29